Atsuko Hata
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Atsuko Hata has a total of 90 co-authors. Here are the top co-authors by number of shared publications:
Daisuke Hata
Department of Pediatrics Medical Research Institute Kitano Hospital, PIIF Tazuke‐kofukai Osaka Japan
5 shared publicationsJunko Kurita
Department of Nursing, Tokiwa University, Ibaraki, Japan
3 shared publicationsTakahide Hata
Department of Pediatrics, Kitano Hospital, Tazuke Kofukai Medical Research Institute, Osaka, Japan
3 shared publicationsYasushi Ohkusa
National Institute of Infectious Diseases, Tokyo, Japan
3 shared publications- Akira Kumakura
Department of Pediatrics, Kitano Hospital, The Tazuke Kofukai Medical Institute, Osaka, Japan
2 shared publications - Daisuke Hata
Department of Pediatrics, Kitano Hospital, Tazuke Kofukai Medical Research Institute, Osaka, Japan
2 shared publications
Latest Publications
- 8 April 2024
- Published by Springer Nature in Pediatric Nephrology
- Vol. 39 (9) , 2637-2640
A case of novel NFKB2 variant with hypertensive emergency and nephrotic syndrome leading to CKD 5D
Nuclear factor kappa B (NF-κB) family plays a central role in the human immune system. Heterozygous variants in NFKB2 typically cause immunodeficiency
- 8 April 2024
- Published by Springer Nature in Pediatric Nephrology
- Vol. 39 (9) , 2637-2640
A case of novel NFKB2 variant with hypertensive emergency and nephrotic syndrome leading to CKD 5D
Nuclear factor kappa B (NF-κB) family plays a central role in the human immune system. Heterozygous variants in NFKB2 typically cause immunodeficiency
- 7 March 2024
- Published by Taylor & Francis in Journal of Chemotherapy
- Vol. 36 (7) , 521-531
Evaluation of predictors of third-generation cephalosporin non-susceptibility and factors affecting recurrence or death in bacteremia caused by Citrobacter freundii complex , Enterobacter cloacae complex, and Klebsiella aerogenes
Factors involved in the susceptibility of third-generation cephalosporins (3GCs) to bacteremia caused by Citrobacter freundii complex, Enterobacter cloacae complex, and Klebsiella aerogenes were investigated based on a case-case-control design. Antimicrobial therapy administered 30 days prior to bacteremia and hospitalization within 90 days were common risk factors for the 3GC susceptible and 3GC non-susceptible groups, while hospitalization from an institution or another hospital was a specific risk factor for the 3GC non-susceptible group. We also attempted to examine the factors affecting the clinical outcome of bacteremia. Hospitalization more than 14 days before the onset of bacteremia was an independent factor indicating poor clinical outcome. In contrast, the implementation of source control was an independent predictor of successful treatment. Although a longer hospital stay before the onset of bacteremia was associated with worse clinical outcomes, implementation of source control may have contributed to improved treatment outcomes for bacteremia.
- 7 March 2024
- Published by Taylor & Francis in Journal of Chemotherapy
- Vol. 36 (7) , 521-531
Evaluation of predictors of third-generation cephalosporin non-susceptibility and factors affecting recurrence or death in bacteremia caused by Citrobacter freundii complex , Enterobacter cloacae complex, and Klebsiella aerogenes
Factors involved in the susceptibility of third-generation cephalosporins (3GCs) to bacteremia caused by Citrobacter freundii complex, Enterobacter cloacae complex, and Klebsiella aerogenes were investigated based on a case-case-control design. Antimicrobial therapy administered 30 days prior to bacteremia and hospitalization within 90 days were common risk factors for the 3GC susceptible and 3GC non-susceptible groups, while hospitalization from an institution or another hospital was a specific risk factor for the 3GC non-susceptible group. We also attempted to examine the factors affecting the clinical outcome of bacteremia. Hospitalization more than 14 days before the onset of bacteremia was an independent factor indicating poor clinical outcome. In contrast, the implementation of source control was an independent predictor of successful treatment. Although a longer hospital stay before the onset of bacteremia was associated with worse clinical outcomes, implementation of source control may have contributed to improved treatment outcomes for bacteremia.
- 1 January 2023
- Published by Wiley in Pediatrics International
- Vol. 65 (1) , e15464
Effects of short‐term treatment with vibegron for refractory nocturnal enuresis
Background: Long‐term nocturnal enuresis treatment leads to stress and lowered self‐esteem for children and their parents. This study evaluated the short‐term effectiveness and safety of vibegron (50 mg) for children with refractory nocturnal enuresis.Methods: A retrospective cohort study of children with therapy‐resistant enuresis was conducted using data for July to December 2019. Enuresis frequency was recorded during 30 days before and after additional vibegron administration with prior treatment. We assessed the treatment effectiveness based on enuresis frequencies between before and after treatment with vibegron 50 mg. Statistical evaluation was performed using a paired t‐test.Results: Among 29 children receiving vibegron, 14 (48.3%) exhibited a partial or complete response to the drug. Enuresis frequencies (mean ± standard deviation [SD]) were, respectively, 15.8 ± 9.2 and 9.5 ± 9.6 before and after treatment with vibegron during the observed 30 days. A statistically significant reduction in enuresis frequency was found (p < 0.001). Moreover, maximum mean±SD morning urine of 200 ± 62.9 mL before treatment with vibegron changed to 232 ± 76.6 mL after treatment. A significant increase in voiding volume in the early morning was found (p < 0.05). No drug‐related severe adverse event was found.Conclusion: Short‐term treatment with vibegron is safe and effective for children with refractory enuresis.
- 1 January 2023
- Published by Wiley in Pediatrics International
- Vol. 65 (1) , e15464
Effects of short‐term treatment with vibegron for refractory nocturnal enuresis
Background: Long‐term nocturnal enuresis treatment leads to stress and lowered self‐esteem for children and their parents. This study evaluated the short‐term effectiveness and safety of vibegron (50 mg) for children with refractory nocturnal enuresis.Methods: A retrospective cohort study of children with therapy‐resistant enuresis was conducted using data for July to December 2019. Enuresis frequency was recorded during 30 days before and after additional vibegron administration with prior treatment. We assessed the treatment effectiveness based on enuresis frequencies between before and after treatment with vibegron 50 mg. Statistical evaluation was performed using a paired t‐test.Results: Among 29 children receiving vibegron, 14 (48.3%) exhibited a partial or complete response to the drug. Enuresis frequencies (mean ± standard deviation [SD]) were, respectively, 15.8 ± 9.2 and 9.5 ± 9.6 before and after treatment with vibegron during the observed 30 days. A statistically significant reduction in enuresis frequency was found (p < 0.001). Moreover, maximum mean±SD morning urine of 200 ± 62.9 mL before treatment with vibegron changed to 232 ± 76.6 mL after treatment. A significant increase in voiding volume in the early morning was found (p < 0.05). No drug‐related severe adverse event was found.Conclusion: Short‐term treatment with vibegron is safe and effective for children with refractory enuresis.
- Open Access
Estimating SARS-CoV-2 reproduction number by infection location in Japan
Background COVID-19 infectiousness might differ by infection location. Nevertheless, no such study of infectiousness has been reported. Object The study objective was estimation of the reproduction number by infection location. Method Patients who infected no one were ignored because their reliability might be lower than that of patients who infected more than one person. On the assumption that the histogram follows an exponential distribution, we estimated the reproduction number from the histogram of the number of people infected by the same patient. Results Night entertainment venues showed the greatest infectiousness, followed by facilities for elderly people and hospitals. Nursery schools and workplaces were followed by homes, with the lowest infectiousness. Discussion and Conclusion Countermeasures under the second declaration of emergency status targeted restaurants. However, infectiousness at restaurants was not high. Comparable to those of universities and karaoke, and not significantly different from homes: the least infectious location studied.
Open AccessEstimating SARS-CoV-2 reproduction number by infection location in Japan
Background COVID-19 infectiousness might differ by infection location. Nevertheless, no such study of infectiousness has been reported. Object The study objective was estimation of the reproduction number by infection location. Method Patients who infected no one were ignored because their reliability might be lower than that of patients who infected more than one person. On the assumption that the histogram follows an exponential distribution, we estimated the reproduction number from the histogram of the number of people infected by the same patient. Results Night entertainment venues showed the greatest infectiousness, followed by facilities for elderly people and hospitals. Nursery schools and workplaces were followed by homes, with the lowest infectiousness. Discussion and Conclusion Countermeasures under the second declaration of emergency status targeted restaurants. However, infectiousness at restaurants was not high. Comparable to those of universities and karaoke, and not significantly different from homes: the least infectious location studied.
- Open Access
An Estimation of Reproduction Number of SARS-CoV-2 by Age Class for Age Classes in Japan
Background Infectiousness of COVID-19 by age class inferred from the infection source and by infected people might be different. However, studies of such infectiousness have not been reported. Object The object of this study was estimation of reproduction numbers by age class of the source of infection and the infected persons. To do so, after examining a new procedure for reproduction number estimation, we checked infected places by age class of the source of infection and the infected persons. Method We ignore patients who infected no one because their reliability might be lower than that of patients who infected more than one person. We estimated the reproduction number from the histogram of the number of the infected people by the same patient, assuming that the histogram follows an exponential distribution. Discussion and Conclusion The obtained results demonstrated that the effective reproduction numbers for infection from children were very low. They were higher among adult and elderly people than among the same age class. Moreover, although the highest and second-highest infected places were ‘other’ and ‘at home’ with some exceptions, the data for infection at hospitals were remarkable among adults and elderly people. Among elderly people, infection at facilities for elderly was also high. Infections at nursing schools, schools, restaurants, and entertainment venues at night were negligible.
Open AccessAn Estimation of Reproduction Number of SARS-CoV-2 by Age Class for Age Classes in Japan
Background Infectiousness of COVID-19 by age class inferred from the infection source and by infected people might be different. However, studies of such infectiousness have not been reported. Object The object of this study was estimation of reproduction numbers by age class of the source of infection and the infected persons. To do so, after examining a new procedure for reproduction number estimation, we checked infected places by age class of the source of infection and the infected persons. Method We ignore patients who infected no one because their reliability might be lower than that of patients who infected more than one person. We estimated the reproduction number from the histogram of the number of the infected people by the same patient, assuming that the histogram follows an exponential distribution. Discussion and Conclusion The obtained results demonstrated that the effective reproduction numbers for infection from children were very low. They were higher among adult and elderly people than among the same age class. Moreover, although the highest and second-highest infected places were ‘other’ and ‘at home’ with some exceptions, the data for infection at hospitals were remarkable among adults and elderly people. Among elderly people, infection at facilities for elderly was also high. Infections at nursing schools, schools, restaurants, and entertainment venues at night were negligible.
- Open Access
SARS-CoV-2 infection control implementation based on sources of infection showing directions for three age groups in Japan
Background Some aspects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission in children and adults remain unclear. This report describes different SARS-CoV-2 transmission patterns by age group in Japan. Methods and findings This retrospective observational case series study analyzed transmission patterns of real-time polymerase chain reaction (RT-PCR)-confirmed SARS-CoV-2 infections found by local health authorities and commercial laboratories during January 14 through July 31, 2020 in Japan. After ascertaining the infection source for every symptomatic case as clusters at households, daycare facilities, schools, hospitals and workplaces etc., their associated transmission patterns were analyzed. Identified cases were divided into three groups: underage, < 20; adults, 20–59; and elderly people 60 years old and older. The reproductive number (R)s of respective transmission directions found for the respective age groups were compared. Of 26,986 total cases, 23,746 unknown cases were found, leaving 3,240 ascertained sources of infection (12.0%) comprising 125 (3.9%) underage, 2350 (72.5%) adult, and 765 (23.6%) elderly people. The respective Rs of underage infection sources directed to underage, adult, and elderly people were estimated respectively as 0.0415 (95% CI, 0.0138–0.0691), 1.11 (95% CI, 0.9171–1.3226), and 0.2811 (95% CI, 0.2074–0.3687). The respective Rs of adult infection source directed to underage, adult, and elderly people were estimated respectively as 0.0140 (95% CI, 0.0120–0.0162), 0.5392 (95% CI, 0.5236–0.5550), and 0.1135 (95% CI, 0.1074–0.1197). The respective Rs of elderly infection source directed to underage, adult, and elderly people were estimated as 0.065 (95% CI, 0.0039–0.0091), 0.3264 (95% CI, 0.3059–0.3474), and 0.3991 (95% CI, 0.3757–0.4229). Conclusions The main sources of SARS-CoV-2 infection were adults and elderly people. The R of underage people directed to adults was greater than 1 because of close familial contact but they were unlikely to become carriers transmitting SARS-CoV-2 because they accounted for a minority for transmissions. Apparently, SARS-CoV-2 was transmitted among adults and elderly people, suggesting that infection control of SARS-CoV-2 should be managed specifically by generation.
Open AccessSARS-CoV-2 infection control implementation based on sources of infection showing directions for three age groups in Japan
Background Some aspects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission in children and adults remain unclear. This report describes different SARS-CoV-2 transmission patterns by age group in Japan. Methods and findings This retrospective observational case series study analyzed transmission patterns of real-time polymerase chain reaction (RT-PCR)-confirmed SARS-CoV-2 infections found by local health authorities and commercial laboratories during January 14 through July 31, 2020 in Japan. After ascertaining the infection source for every symptomatic case as clusters at households, daycare facilities, schools, hospitals and workplaces etc., their associated transmission patterns were analyzed. Identified cases were divided into three groups: underage, < 20; adults, 20–59; and elderly people 60 years old and older. The reproductive number (R)s of respective transmission directions found for the respective age groups were compared. Of 26,986 total cases, 23,746 unknown cases were found, leaving 3,240 ascertained sources of infection (12.0%) comprising 125 (3.9%) underage, 2350 (72.5%) adult, and 765 (23.6%) elderly people. The respective Rs of underage infection sources directed to underage, adult, and elderly people were estimated respectively as 0.0415 (95% CI, 0.0138–0.0691), 1.11 (95% CI, 0.9171–1.3226), and 0.2811 (95% CI, 0.2074–0.3687). The respective Rs of adult infection source directed to underage, adult, and elderly people were estimated respectively as 0.0140 (95% CI, 0.0120–0.0162), 0.5392 (95% CI, 0.5236–0.5550), and 0.1135 (95% CI, 0.1074–0.1197). The respective Rs of elderly infection source directed to underage, adult, and elderly people were estimated as 0.065 (95% CI, 0.0039–0.0091), 0.3264 (95% CI, 0.3059–0.3474), and 0.3991 (95% CI, 0.3757–0.4229). Conclusions The main sources of SARS-CoV-2 infection were adults and elderly people. The R of underage people directed to adults was greater than 1 because of close familial contact but they were unlikely to become carriers transmitting SARS-CoV-2 because they accounted for a minority for transmissions. Apparently, SARS-CoV-2 was transmitted among adults and elderly people, suggesting that infection control of SARS-CoV-2 should be managed specifically by generation.
- 1 November 2019
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 144 (5) , e20190672
Successful Conservative Treatment of Mycotic Pulmonary Artery Aneurysms Caused by MRSA Bacteremia
Mycotic pulmonary artery aneurysms (MPAAs) are rare and life-threatening with currently no recommended treatment strategies. In this report, we describe a successfully treated case of ventricular septal defect in an 11-month-old girl who developed bacteremia, infective endocarditis, and MPAA caused by methicillin-resistant Staphylococcus aureus (MRSA). We first started vancomycin, gentamycin, and panipenem-betamipron for infective endocarditis but switched to teicoplanin and arbekacin on day 3 after initiating treatment because bacteremia persisted, and vancomycin minimum inhibitory concentration was relatively high at 2 mg/L. Although we added clindamycin on day 5 and fosfomycin on day 7, MRSA bacteremia persisted, and we finally added daptomycin at 10 mg/kg per day on day 8, whereupon the bacteremia subsided within a day. Although the bacteremia subsided, the patient developed septic pulmonary embolisms and septic arthritis on her left knee. We continued daptomycin but switched the concomitant drug to linezolid, trimethoprim-sulfamethoxazole, and rifampicin on day 11. After several repeats of puncture and lavage of her knee joint, she became afebrile on day 16. Computed tomography scans taken on day 32 revealed right pulmonary artery MPAAs. She was treated with long-term multidrug therapy, and MPAAs were absent on subsequent computed tomography scans on day 184. Multidrug therapy mainly based on daptomycin could be a possible salvage therapy for refractory MRSA bacteremia with high vancomycin minimum inhibitory concentration. Conservative treatment should be selectively considered as a treatment option for clinically stable MPAA instead of surgical and endovascular treatment.
- 1 November 2019
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 144 (5) , e20190672
Successful Conservative Treatment of Mycotic Pulmonary Artery Aneurysms Caused by MRSA Bacteremia
Mycotic pulmonary artery aneurysms (MPAAs) are rare and life-threatening with currently no recommended treatment strategies. In this report, we describe a successfully treated case of ventricular septal defect in an 11-month-old girl who developed bacteremia, infective endocarditis, and MPAA caused by methicillin-resistant Staphylococcus aureus (MRSA). We first started vancomycin, gentamycin, and panipenem-betamipron for infective endocarditis but switched to teicoplanin and arbekacin on day 3 after initiating treatment because bacteremia persisted, and vancomycin minimum inhibitory concentration was relatively high at 2 mg/L. Although we added clindamycin on day 5 and fosfomycin on day 7, MRSA bacteremia persisted, and we finally added daptomycin at 10 mg/kg per day on day 8, whereupon the bacteremia subsided within a day. Although the bacteremia subsided, the patient developed septic pulmonary embolisms and septic arthritis on her left knee. We continued daptomycin but switched the concomitant drug to linezolid, trimethoprim-sulfamethoxazole, and rifampicin on day 11. After several repeats of puncture and lavage of her knee joint, she became afebrile on day 16. Computed tomography scans taken on day 32 revealed right pulmonary artery MPAAs. She was treated with long-term multidrug therapy, and MPAAs were absent on subsequent computed tomography scans on day 184. Multidrug therapy mainly based on daptomycin could be a possible salvage therapy for refractory MRSA bacteremia with high vancomycin minimum inhibitory concentration. Conservative treatment should be selectively considered as a treatment option for clinically stable MPAA instead of surgical and endovascular treatment.
- 1 March 2019
- Published by Elsevier in Journal of Diabetes and its Complications
- Vol. 33 (3) , 243-248
Altered immunogenicity of 23-valent pneumococcal polysaccharide vaccine in elderly patients with diabetes who revealed lower responses to concomitant administration of BIKEN varicella zoster vaccine: Results of post hoc analysis of a randomized double-blind trial
- 1 March 2019
- Published by Elsevier in Journal of Diabetes and its Complications
- Vol. 33 (3) , 243-248
Altered immunogenicity of 23-valent pneumococcal polysaccharide vaccine in elderly patients with diabetes who revealed lower responses to concomitant administration of BIKEN varicella zoster vaccine: Results of post hoc analysis of a randomized double-blind trial
- 29 October 2017
- Published by Wiley in Pediatrics International
- Vol. 59 (10) , 1116-1118
Herpes zoster meningitis in immunocompetent children: Two case reports and a literature review
We encountered two cases of Herpes zoster (HZ) meningitis, a rarely occurring complication of HZ, in previously healthy children. One patient treated with i.v. acyclovir (ACV, 31 mg/kg/day) did not recover. His symptoms were relieved somewhat by increased ACV dosage, but it caused transient renal dysfunction. Another patient treated with i.v. ACV (30 mg/kg/day) recovered. Treatment for HZ meningitis in immunocompetent children has not been established. In a literature review, 80% of 20 patients were treated with the usual dose of ACV 15–30 mg/kg/day. The present cases suggest that a high dosage of ACV up to 60 mg/kg/day should be considered (while monitoring for side‐effects) unless symptoms improve. In the review, one of every three vaccine‐strain Varicella zoster virus (VZV) cases was severe, whereas the present cases resulted from wild type. Further investigations must examine different clinical characteristics of HZ meningitis caused by wild‐type and vaccine‐strain VZV.
- 29 October 2017
- Published by Wiley in Pediatrics International
- Vol. 59 (10) , 1116-1118
Herpes zoster meningitis in immunocompetent children: Two case reports and a literature review
We encountered two cases of Herpes zoster (HZ) meningitis, a rarely occurring complication of HZ, in previously healthy children. One patient treated with i.v. acyclovir (ACV, 31 mg/kg/day) did not recover. His symptoms were relieved somewhat by increased ACV dosage, but it caused transient renal dysfunction. Another patient treated with i.v. ACV (30 mg/kg/day) recovered. Treatment for HZ meningitis in immunocompetent children has not been established. In a literature review, 80% of 20 patients were treated with the usual dose of ACV 15–30 mg/kg/day. The present cases suggest that a high dosage of ACV up to 60 mg/kg/day should be considered (while monitoring for side‐effects) unless symptoms improve. In the review, one of every three vaccine‐strain Varicella zoster virus (VZV) cases was severe, whereas the present cases resulted from wild type. Further investigations must examine different clinical characteristics of HZ meningitis caused by wild‐type and vaccine‐strain VZV.
- Open Access
- 1 August 2017
- Published by Elsevier in Journal of Microbiology, Immunology and Infection
- Vol. 50 (4) , 541-544
Safety and efficacy of anti-influenza drugs, intravenous peramivir against influenza virus infection in elderly patients with underlying disease
- 1 August 2017
- Published by Elsevier in Journal of Microbiology, Immunology and Infection
- Vol. 50 (4) , 541-544
Open AccessSafety and efficacy of anti-influenza drugs, intravenous peramivir against influenza virus infection in elderly patients with underlying disease